ReviewFrontiers in immunology2024

The immunological bases of alemtuzumab as induction-therapy in pediatric-onset multiple sclerosis.

Marco Puthenparampil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.